Eighty percent of bowel cancers halted with existing medicines

1 octubre 2014

More than 80 percent of bowel cancers could be treated with existing drugs, an international team of scientists say at the conclusion of their study. The study found that medicines called ‘JAK inhibitors’ halted tumor growth in bowel cancers with a genetic mutation that is present in more than 80 per cent of bowel cancers. Multiple JAK inhibitors are currently used, or are in clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood cancers and myeloproliferative disorders.